QUANTIFYING PATIENT PRIORITIES FOR CLINICAL EVIDENCE ON THE IMPACT OF OSSEOINTEGRATED LIMB PROSTHESES

Award details are derived from public USAspending.gov records. Not a bid recommendation.

Award details

Award ID: 75F40123C00138
Contractor
Awarding agency: Department of Health and Human Services
Sub-agency / office: Food and Drug Administration
Award amount: $748,889
Period of performance: Sep 5, 2023 – Sep 18, 2026
NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSC: PSC AN11
Place of performance: MD

Discover comparable awards, related contractors, and agency purchasing history.

Same agency and NAICS · 75A50126C00004 — LATE-STAGE DEVELOPMENT, FDA MARKETING AUTHORIZATION, PROCUREMENT, AND STOCKPILE OF ANTIBIOTICS FOR THE TREA… · Department of Health and Human Services · $156,103,541
Same agency and NAICS · 75A50126C00002 — NON SURGICAL DEBRIDEMENT · Department of Health and Human Services · $34,880,933
Same agency and NAICS · 75F40126C00112 — EO14398 - BROAD AGENCY ANNOUNCEMENT (BAA) FY26C1IP3 - ADVANCED RESEARCH AND DEVELOPMENT OF REGULATORY SCIEN… · Department of Health and Human Services · $1,456,427
Same agency and NAICS · 75N93026F00002 — DIAGNOSTIC DEVELOPMENT SERVICES · Department of Health and Human Services · $1,010,033
Same agency and NAICS · 75F40126C00098 — NEXT GENERATION PROCESS DEVELOPMENT AND QUALITY CONTROL IN PROTEIN LYOPHILIZATION USING MECHANISTIC AND AI… · RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH · Department of Health and Human Services · $733,525
Same agency and NAICS · 75A50126F61020 — TWO-WAY IMMUNOGENICITY TESTING ON EXISTING CLINICAL TRIAL SERA TO IMMUNOGENICITY SUPERIORITY OF A NEW VACCI… · Department of Health and Human Services · $493,470